Dar Al Dawa Development and Investment Co. Ltd.'s latest marketcap:
As of 07/05/2025, Dar Al Dawa Development and Investment Co. Ltd.'s market capitalization has reached $57.26 M. According to our data, Dar Al Dawa Development and Investment Co. Ltd. is the 28747th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 57.26 M |
Revenue (ttm) | 116.89 M |
Net Income (ttm) | 5.2 M |
Shares Out | 35 M |
EPS (ttm) | 0.15 |
Forward PE | 0.00 |
Ex-Dividend Date | n/a |
Earnings Date | 07/31/2025 |
Dar Al Dawa Development and Investment Co. Ltd.'s yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/05/2025 | د.أ57.26 M | -7.94% | 28747 |
12/31/2024 | د.أ44.1 M | -4.55% | 26462 |
12/31/2023 | د.أ46.2 M | 23.36% | 26008 |
12/29/2022 | د.أ37.45 M | -6.96% | 26496 |
12/30/2021 | د.أ40.25 M | 40% | 26784 |
12/31/2020 | د.أ28.75 M | 8.49% | 25888 |
12/31/2019 | د.أ26.5 M | 19.1% | 23467 |
12/31/2018 | د.أ22.25 M | -52.41% | 23411 |
12/31/2017 | د.أ46.75 M | -13.02% | 20167 |
12/29/2016 | د.أ53.75 M | -7.33% | 17269 |
Company Profile
About Dar Al Dawa Development and Investment Co. Ltd.
Dar Al Dawa Development and Investment Co. Ltd. is a leading integrated pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of pharmaceutical and consumer healthcare products. With a strong presence across multiple regions, the company serves markets in:
- Levant, Gulf, and Yemen
- The Middle East
- Africa
- Europe
- Asia
Business Segments
The company operates through two key segments:
- Medicine: Offers a wide range of pharmaceutical products across various therapeutic areas.
- Infants’ Cereals and Milk Formula: Provides specialized nutrition products for infants.
Therapeutic Areas
Dar Al Dawa’s pharmaceutical portfolio covers multiple therapeutic categories, including:
- Anti-infective
- Cardiovascular and diabetes
- Urology
- Respiratory
- Gastrointestinal
- Analgesic and musculoskeletal
- Central nervous system
- Gynecology
- Dermatology
- Ophthalmology
- Oncology
Company Overview
Founded in 1975, Dar Al Dawa Development and Investment Co. Ltd. is headquartered in Amman, Jordan. The company is committed to serving patients and medical communities with high-quality healthcare solutions.
Frequently Asked Questions
-
What is Dar Al Dawa Development and Investment Co. Ltd.'s (ASE-DADI) current market cap?As of 07/05/2025, Dar Al Dawa Development and Investment Co. Ltd. (including the parent company, if applicable) has an estimated market capitalization of $57.26 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dar Al Dawa Development and Investment Co. Ltd. (ASE-DADI) rank globally by market cap?Dar Al Dawa Development and Investment Co. Ltd. global market capitalization ranking is approximately 28747 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.